protocol de les activitats per al cribratge del cà ncer de coll uterà a l ...
protocol de les activitats per al cribratge del cà ncer de coll uterà a l ...
protocol de les activitats per al cribratge del cà ncer de coll uterà a l ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
06/06/2006 Protocol <strong>cribratge</strong> càncer <strong>de</strong> <strong>coll</strong> uterí.<br />
• Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natur<strong>al</strong> history of cervic<strong>al</strong> human<br />
papillomavirus infection in young women. N Engl J Med 1998;338:423-8.<br />
• Hogewoning CJA, Bleeker MCG, van <strong>de</strong>n Brule, AJC Voorhorst FJ, Snij<strong>de</strong>rs PJF, Berkhof J et <strong>al</strong>.<br />
Condom use promotes regression of cervic<strong>al</strong> intraepitheli<strong>al</strong> neoplasia and clearance of human<br />
papillomavirus: a randomized clinic<strong>al</strong> tri<strong>al</strong>. Int J Cancer 2003;107:811-6.<br />
• IARC, Internation<strong>al</strong> Agency for Research on Cancer. Cervic<strong>al</strong> cancer screening. Lyon: IARC Press,<br />
abril 2005.<br />
• Iftner T, Villa LL. Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003;31:80-8.<br />
• Muñoz N, Bosch FX, <strong>de</strong> Sanjose S, Herrero R, Castellsagué X, Shah KV, Snij<strong>de</strong>rs PJ, Meijer CJ.<br />
Epi<strong>de</strong>miologic classification of human papillomavirus types associated with cervic<strong>al</strong> cancer. N Engl<br />
J Med 2003;348:518-27.<br />
• Nobbenhuis MA, W<strong>al</strong>boomers JM, Helmerhorst TJ, Rozenda<strong>al</strong> L, Remmink AJ, Risse EK, Van <strong>de</strong>r<br />
Lin<strong>de</strong>n HC, Voorhorst FJ, Kenemans P, Meijer CJ. Relation of human papillomavirus status to<br />
cervic<strong>al</strong> <strong>les</strong>ions and consequences for cervic<strong>al</strong>-cancer screening: a prospective study. Lancet<br />
1999;354:20-5.<br />
• Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J & (editors). (1997) Cancer Inci<strong>de</strong>nce in Five<br />
Continents, Vol. VII. Lyon, Internation<strong>al</strong> Agency for Research on Cancer.<br />
• Solomon D, Davey D, Kurman R, Moriarty A et <strong>al</strong>. The 2001 Bethesda system: terminology for<br />
reporting results of cervic<strong>al</strong> cytology. JAMA 2002;287(16):2114-9.<br />
• Simsir A, Carter W, Elgert P, Cangiarella J. Reporting endometri<strong>al</strong> cells in women 40 years and<br />
ol<strong>de</strong>r: assessing the clinic<strong>al</strong> usefulness of Bethesda 2001. Am J Clin Pathol 2005;123:571-5.<br />
• Wright TC Jr, Schiffman M. Adding a test for human papillomavirus DNA to cervic<strong>al</strong>-cancer<br />
screening. N Engl J Med 2003;348:489-90.<br />
• http://bethesda2001.cancer.gov/terminology.html.<br />
• http://www.cytopathology.org/NIH/atlas.php.<br />
• http://www.nccn.org/profession<strong>al</strong>s/physician_gls/PDF/cervic<strong>al</strong>_screening.pdf.<br />
• http://www.cancer-network.<strong>de</strong>/cervic<strong>al</strong>/sp_in<strong>de</strong>x.htm.<br />
• http://europa.eu.int/comm/he<strong>al</strong>th/ph_<strong>de</strong>terminants/genetics/cancer_screening_en.pdf.<br />
29